Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.